Besides, another metabolite, LPS, involved in infectious diseases has recently shown to have some effects on atherosclerosis based on in experimental and clinical trials by binding to various proteins, such as LBP, CD14, TLR-4, and MD-2. Here, LBP is linked to infectious disease.